We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




RFA Safe for Treating Liver Tumors

By HospiMedica staff writers
Posted on 22 Nov 2004
A study has found radiofrequency ablation (RFA) a safe and effective treatment for eradicating liver tumors in contact with the gastrointestinal (GI) tract.

The study analyzed 41 patients with a liver tumor abutting the GI tract. More...
After RFA ablation was performed on these patients, 34 of the 41 tumors were found to be eradicated, with no bowel-related complications. Previously, investigators have warned that RFA might cause injuries when tumors are touching the GI tract. The study was conducted by researchers at the Samsung Medical Center (Seoul, South Korea).

In a second study, conducted at Brigham and Women's Hospital (Boston, MA, USA), researchers found that injecting alcohol into a liver tumor immediately prior to RFA makes the procedure more effective, in that more of the tumor is destroyed, so patients can undergo fewer RFA treatments. They found that the combination is also effective in other parts of the body.

"We have used the combination therapy successfully in other parts of the body, such as with bone and soft-tissue tumors. However, the combination must be used carefully in areas where alcohol leakage could be deleterious, such as in the lung where normal tissue may be affected,” said lead author Sridhar Shankar, M.D., of the University of Massachusetts, Worcester (USA). Both studies were published in the November 2004 issue of the American Journal of Roentgenology.


Gold Member
Blood Gas Analyzer
i-Check200
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Pediatric Mask
Respire SOFT
Fetal Monitor
BT-380
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.